Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Hypertonic Saline in COPD
NCT02266875Phase 4Completed
- Sponsor
- OhioHealth
- Start
- Oct 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of hypertonic saline in chronic obstructive pulmonary disease (COPD), sponsored by OhioHealth. Started Oct 2014; status: completed.
02
Drugs
hypertonic saline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02266875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266875.